Double maintains 1 strategies that include MGNX - MacroGenics, Inc.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CRBU | 52.25% | $119.05M | -21.95% | 0.00% |
XNCR | 51.52% | $594.99M | -57.00% | 0.00% |
RGNX | 48.82% | $431.83M | -29.81% | 0.00% |
BEAM | 47.12% | $1.71B | -26.67% | 0.00% |
KOD | 46.73% | $186.26M | +35.25% | 0.00% |
FATE | 46.63% | $138.71M | -64.52% | 0.00% |
CRSP | 46.45% | $3.84B | -26.65% | 0.00% |
NTLA | 45.71% | $994.40M | -61.29% | 0.00% |
SYRE | 45.55% | $910.13M | -41.53% | 0.00% |
ARWR | 45.40% | $2.16B | -33.74% | 0.00% |
GBIO | 45.36% | $24.13M | -86.67% | 0.00% |
ARCT | 45.25% | $334.94M | -52.43% | 0.00% |
KN | 45.15% | $1.48B | -2.01% | 0.00% |
DNLI | 44.41% | $2.05B | -31.67% | 0.00% |
ATXS | 44.24% | $332.40M | -34.48% | 0.00% |
PGEN | 43.82% | $439.82M | -5.10% | 0.00% |
RXRX | 43.53% | $2.08B | -47.32% | 0.00% |
CERS | 43.33% | $256.15M | -20.71% | 0.00% |
IMNM | 42.95% | $768.32M | -33.51% | 0.00% |
ALLO | 42.84% | $282.16M | -42.15% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CBOE | -17.65% | $23.83B | +34.36% | 1.10% |
PHYS | -11.35% | - | - | 0.00% |
GFI | -10.74% | $21.77B | +73.47% | 2.28% |
LITB | -10.37% | $22.07M | -76.50% | 0.00% |
TEF | -10.10% | $29.46B | +22.25% | 9.27% |
HMY | -9.85% | $8.95B | +63.97% | 1.21% |
AMT | -9.84% | $100.87B | +11.78% | 3.09% |
CME | -9.79% | $98.05B | +38.45% | 3.91% |
ED | -9.01% | $36.29B | +11.44% | 3.33% |
DRD | -8.20% | $1.22B | +67.74% | 1.99% |
AU | -7.47% | $24.23B | +110.59% | 2.17% |
EXC | -7.01% | $42.77B | +21.44% | 3.67% |
AWK | -6.44% | $27.52B | +8.15% | 2.21% |
COR | -6.27% | $57.52B | +25.11% | 0.73% |
AEM | -5.99% | $62.00B | +89.83% | 1.31% |
ULS | -5.93% | $14.21B | +71.62% | 0.72% |
K | -5.74% | $27.39B | +34.25% | 2.89% |
MDLZ | -5.61% | $85.91B | +0.27% | 2.73% |
VSTA | -5.58% | $350.48M | +43.28% | 0.00% |
FTS | -5.46% | $23.74B | +23.03% | 3.69% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
SPSB | 0.05% | $8.24B | 0.04% |
SLQD | -0.13% | $2.27B | 0.06% |
VCSH | -0.19% | $34.10B | 0.03% |
BSCS | -0.20% | $2.62B | 0.1% |
GOAU | -0.24% | $127.29M | 0.6% |
DBE | 0.24% | $54.06M | 0.77% |
NUAG | 0.25% | $58.18M | 0.19% |
MUNI | 0.27% | $1.99B | 0.35% |
BSCV | -0.34% | $1.04B | 0.1% |
AGGY | 0.38% | $778.16M | 0.12% |
IGSB | 0.41% | $21.26B | 0.04% |
JSI | 0.49% | $834.92M | 0.49% |
FXC | -0.52% | $93.50M | 0.4% |
TFLO | -0.52% | $6.92B | 0.15% |
BSCU | -0.59% | $1.62B | 0.1% |
SCHI | -0.60% | $8.56B | 0.03% |
GDXJ | 0.61% | $5.68B | 0.51% |
CANE | -0.63% | $9.87M | 0.29% |
USL | 0.67% | $44.65M | 0.85% |
GSST | -0.68% | $900.18M | 0.16% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TAIL | -33.58% | $101.78M | 0.59% |
BTAL | -33.56% | $291.48M | 1.43% |
VIXY | -31.55% | $185.08M | 0.85% |
TPMN | -20.39% | $30.91M | 0.65% |
FXY | -19.28% | $853.67M | 0.4% |
IVOL | -18.62% | $349.05M | 1.02% |
AGZ | -17.85% | $608.84M | 0.2% |
SPTS | -17.44% | $5.74B | 0.03% |
IEI | -17.43% | $15.31B | 0.15% |
VGSH | -17.04% | $22.55B | 0.03% |
TYA | -16.98% | $147.80M | 0.15% |
UTWO | -16.94% | $372.79M | 0.15% |
IBTH | -16.72% | $1.58B | 0.07% |
VGIT | -16.72% | $31.64B | 0.04% |
IBTL | -16.62% | $374.15M | 0.07% |
SPTI | -16.35% | $8.63B | 0.03% |
IBTK | -16.31% | $433.18M | 0.07% |
IBTJ | -16.25% | $676.32M | 0.07% |
ULST | -16.23% | $668.01M | 0.2% |
SCHR | -15.54% | $10.71B | 0.03% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
GNOM | 57.22% | $43.17M | 0.5% |
XBI | 56.92% | $4.66B | 0.35% |
ARKG | 53.11% | $1.02B | 0.75% |
IBB | 52.58% | $5.44B | 0.45% |
PBE | 50.38% | $222.71M | 0.58% |
IWC | 49.86% | $801.78M | 0.6% |
KJUL | 48.09% | $117.87M | 0.79% |
IWO | 48.08% | $11.30B | 0.24% |
CPRJ | 47.84% | $47.04M | 0.69% |
FBT | 47.30% | $997.89M | 0.54% |
IWM | 46.89% | $62.96B | 0.19% |
PTH | 46.88% | $101.31M | 0.6% |
VTWO | 46.69% | $12.19B | 0.07% |
XPH | 46.61% | $148.95M | 0.35% |
BBH | 46.57% | $336.53M | 0.35% |
ARKK | 46.56% | $6.06B | 0.75% |
GSSC | 46.44% | $542.27M | 0.2% |
SCHA | 46.16% | $16.76B | 0.04% |
ESML | 45.66% | $1.78B | 0.17% |
QDVO | 45.23% | $69.54M | 0.55% |
Current Value
$1.391 Year Return
Current Value
$1.391 Year Return
SeekingAlpha
MacroGenics' recent royalty deal extends cash runway, but liquidity concerns remain, and further asset sales or dilution may be necessary. Read why MGNX is a Buy.
Yahoo
MacroGenics received $70 million upfront cash payment from Sagard Healthcare Partners (Sagard)MacroGenics’ cash runway extended through first half of 2027 ROCKVILLE, MD, June 10, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative antibody-based therapeutics for the treatment of cancer, today announced that it has entered into a royalty purchase agreement with Sagard
Finnhub
MacroGenics, Inc. announced that it has entered into a royalty purchase agreement with Sagard in exchange for a capped royalty interest on future global net sales of ZYNYZ . ZYNYZ is a PD-1 inhibitor...
Finnhub
Presenter SpeechEric Risser My pleasure to kick things off this morning. My name is Eric Risser. I'm the Chief Operating Officer at MacroGenics, and I'm joined by my colleague, Jim Karrels, our
Yahoo
ROCKVILLE, MD, June 03, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative antibody-based therapeutics for the treatment of cancer, today announced that members of the Company’s management team will present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025 on Tuesday, June 10, 2025, at 8:00am ET in Miami, FL. A webcast of the above presentation may be accessed und
Yahoo
MacroGenics, Inc. ( NASDAQ:MGNX ) defied analyst predictions to release its first-quarter results, which were ahead of...
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
SO | -0.01% | $97.41B | +13.72% | 3.27% |
TR | -0.03% | $2.47B | +22.26% | 1.33% |
FSM | 0.08% | $2.07B | +35.27% | 0.00% |
WTRG | -0.08% | $10.48B | +1.11% | 3.49% |
WRB | -0.11% | $27.61B | +38.77% | 0.49% |
EGO | -0.12% | $4.30B | +41.04% | 0.00% |
WPM | -0.21% | $41.33B | +72.84% | 0.71% |
ZCMD | -0.29% | $30.81M | +6.09% | 0.00% |
CRESY | -0.29% | $667.50M | +33.21% | 5.58% |
SJM | 0.30% | $10.21B | -14.59% | 4.50% |
CHT | -0.39% | $35.82B | +16.35% | 3.17% |
EQNR | 0.49% | $76.07B | +6.46% | 5.15% |
CMS | 0.56% | $20.58B | +16.71% | 3.05% |
SAND | -0.61% | $2.69B | +68.62% | 0.63% |
UL | -0.80% | $152.43B | +10.56% | 3.14% |
TMUS | -0.80% | $250.92B | +24.42% | 1.48% |
DG | -0.81% | $24.72B | -11.28% | 2.10% |
XASAX | -0.81% | - | - | 0.15% |
DOGZ | 0.86% | $375.43M | +86.17% | 0.00% |
MNOV | -0.88% | $62.29M | -3.05% | 0.00% |